Literature DB >> 8766527

Inhibition of natural killer cell cytotoxicity by cell growth-related molecules.

Y Tamura1, S Takashima, J M Cho, W Qi, K Kamiguchi, T Torigoe, S Takahashi, I Hirai, N Sato, K Kikuchi.   

Abstract

Certain MHC class I molecules on target cells are known to inhibit the cytotoxic action of NK cells. By using monoclonal antibody (mAb) Cho-1, we have found inhibitory non-MHC class I cell surface molecules that are noncovalently-associated with 200 kDa and 40 kDa antigens. Poly I-C-induced rat NK cells were not cytotoxic to rat fetus-derived fibroblast WFB cell line. In contrast, NK cells were cytotoxic to H-ras oncogene-induced transformants of WFB, W14 and W31. FACS analysis indicated that mAb Cho-1 reacts with WFB, but not with W14 and W31 cells. Thus, this antigen may disappear concomitantly with cell growth and transformation. Cho-1 antigens were also expressed on other NK-resistant lines, such as mouse BALB3T3 fibroblast, EL-4 lymphoma and human fibroblast HEPM. However, they were not expressed on NK-sensitive mouse YAC-1 and H-ras transformant (Brash) of BALB3T3 cells. Furthermore, treatment of target cells with IFN-gamma clearly induced the cell surface expression of Cho-1 antigens, and conferred a resistance to NK cytolysis on target cells. These data strongly suggest that Cho-1 antigen expression may correlate with target cell susceptibility to NK cells. Indeed, treatment of NK-resistant WFB as well as HEPM cells with F(ab')2 fragments of mAb Cho-1 resulted in the acquisition of susceptibility to NK cytolysis. Cho-1 antigens may be novel molecules that regulate the NK resistance of cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766527      PMCID: PMC5921145          DOI: 10.1111/j.1349-7006.1996.tb00269.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  34 in total

Review 1.  Candidate natural killer cell receptors.

Authors:  E Hofer; M Düchler; S A Fuad; J P Houchins; T Yabe; F H Bach
Journal:  Immunol Today       Date:  1992-11

Review 2.  Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules.

Authors:  W J Storkus; J R Dawson
Journal:  Crit Rev Immunol       Date:  1991       Impact factor: 2.214

Review 3.  Mechanism of cytotoxicity by natural killer (NK) cells.

Authors:  R B Herberman; C W Reynolds; J R Ortaldo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

4.  Express yourself or die: peptides, MHC molecules, and NK cells.

Authors:  K Kärre
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

5.  70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity.

Authors:  Y Tamura; N Tsuboi; N Sato; K Kikuchi
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

6.  Inhibition of T cell activation by the extracellular matrix protein tenascin.

Authors:  T J Hemesath; L S Marton; K Stefansson
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

7.  Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules.

Authors:  J C Ryan; J Turck; E C Niemi; W M Yokoyama; W E Seaman
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

8.  Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules.

Authors:  K P Kane
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

9.  Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells.

Authors:  R Glas; K Sturmhöfel; G J Hämmerling; K Kärre; H G Ljunggren
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

10.  Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.

Authors:  R M Welsh; J O Brubaker; M Vargas-Cortes; C L O'Donnell
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  2 in total

1.  Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Authors:  Kowichi Jimbow; Yasue Ishii-Osai; Shosuke Ito; Yasuaki Tamura; Akira Ito; Akihiro Yoneta; Takafumi Kamiya; Toshiharu Yamashita; Hiroyuki Honda; Kazumasa Wakamatsu; Katsutoshi Murase; Satoshi Nohara; Eiichi Nakayama; Takeo Hasegawa; Itsuo Yamamoto; Takeshi Kobayashi
Journal:  J Skin Cancer       Date:  2013-02-21

2.  Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis.

Authors:  A L Spinardi; R Kaneno; M A Rodrigues; D M Salvadori; N S Rocha; L F Barbisan; L R Ribeiro; J L de Camargo
Journal:  Jpn J Cancer Res       Date:  1999-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.